Glenmark Pharmaceuticals Ltd.

GLENMARK

Market Cap
₹40,501 Cr.
P/E
0.00

Glenmark Pharmaceuticals Ltd.

About
Glenmark Pharmaceuticals Limited is dedicated to developing new chemical and biological entities. Their drug discovery efforts target inflammation, metabolic disorders, and pain. The company's formula… Read more
Glenmark Pharmaceuticals Limited is dedicated to developing new chemical and biological entiti… Read more
Low
722
52W Range
High
1454
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
3.14%
3yr Average
9.08%
5yr Average
11.3%
Net Profit Margin
Latest
2.29%
3yr Average
6.27%
5yr Average
7.09%
ROCE
Latest
15.85%
3yr Average
17.22%
5yr Average
17.22%
Debt to Equity
Latest
0.46
3yr Average
0.51
5yr Average
0.62
Market Share
1.90 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
15 %
(as of Mar 18)
Source/Historic
Anti Dandruff Shampoo (Scalpe+) Market Share
2.38 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.35 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
4.12 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
8.80 %
(as of Nov 21)
Historic
Dermatology - Market Share
Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Glenmark Pharma (Branded generics)

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    • EPL Ltd.
    • Borosil Renewables Ltd.
    • GMM Pfaudler Ltd.
    • AGI Greenpac Ltd.
    • Shaily Engineering Plastics Ltd.
    FAQs on Glenmark Pharmaceuticals Ltd. Business

    Glenmark Pharmaceuticals focuses on developing innovative drugs in inflammation, metabolic disorders, and pain, with a formulations business spanning multiple regions and therapeutic areas.

    Glenmark Pharma major competitors are Glaxosmithkline Phar, Gland Pharma, Ipca Laboratories, Ajanta Pharma, JB Chem & Pharma, Pfizer, Natco Pharma.
    Market Cap of Glenmark Pharma is ₹40,501 Crs.
    While the median market cap of its peers are ₹29,980 Crs.

    Glenmark Pharma seems to be less financially stable compared to its peers.
    Altman Z score of Glenmark Pharma is 5.08 and is ranked 8 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Glenmark Pharmaceuticals Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline Timeline